Literature DB >> 35264643

Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies.

Suttikiat Changruenngam1,2, Charin Modchang3,4,5, Dominique J Bicout6,7.   

Abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a major threat to global public health. Epidemiological and infection controls associated with CRKP are challenging because of several potential elements involved in a complicated cycle of transmission. Here, we proposed a comprehensive mathematical model to investigate the transmission dynamics of CRKP, determine factors affecting the prevalence, and evaluate the impact of interventions on transmission. The model includes the essential compartments, which are uncolonized, asymptomatic colonized, symptomatic colonized, and relapsed patients. Additionally, symptomatic colonized and relapsed patients were further classified into subpopulations according to their number of treatment failures or relapses. We found that the admission of colonized patients and use of antibiotics significantly impacted the endemic transmission in health care units. Thus, we introduced the treatment efficacy, defined by combining the treatment duration and probability of successful treatment, to characterize and describe the effects of antibiotic treatment on transmission. We showed that a high antibiotic treatment efficacy results in a significantly reduced likelihood of patient readmission in the health care unit. Additionally, our findings demonstrate that CRKP transmission with different epidemiological characteristics must be controlled using distinct interventions.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35264643      PMCID: PMC8907197          DOI: 10.1038/s41598-022-07728-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  97 in total

1.  Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013.

Authors:  A Hoxha; T Kärki; C Giambi; C Montano; A Sisto; A Bella; F D'Ancona
Journal:  J Hosp Infect       Date:  2015-07-29       Impact factor: 3.926

2.  Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.

Authors:  D Ben-David; R Kordevani; N Keller; I Tal; A Marzel; O Gal-Mor; Y Maor; G Rahav
Journal:  Clin Microbiol Infect       Date:  2011-07-01       Impact factor: 8.067

3.  Epidemiology of carbapenem-resistant Gram-negative infections globally.

Authors:  Adrian J Brink
Journal:  Curr Opin Infect Dis       Date:  2019-12       Impact factor: 4.915

4.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study.

Authors:  Yang Jiao; Yanghua Qin; Jiajun Liu; Qiang Li; Yuchao Dong; Yan Shang; Yi Huang; Rui Liu
Journal:  Pathog Glob Health       Date:  2015-02-24       Impact factor: 2.894

5.  Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.

Authors:  Abraham Borer; Lisa Saidel-Odes; Klaris Riesenberg; Seada Eskira; Nejama Peled; Ronit Nativ; Francisc Schlaeffer; Michael Sherf
Journal:  Infect Control Hosp Epidemiol       Date:  2009-10       Impact factor: 3.254

Review 6.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071

Review 7.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

8.  Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010.

Authors:  Guillermo V Sanchez; Ronald N Master; Richard B Clark; Madiha Fyyaz; Padmaraj Duvvuri; Gupta Ekta; Jose Bordon
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

Review 9.  Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods.

Authors:  Chang-Ro Lee; Jung Hun Lee; Kwang Seung Park; Young Bae Kim; Byeong Chul Jeong; Sang Hee Lee
Journal:  Front Microbiol       Date:  2016-06-13       Impact factor: 5.640

10.  Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection.

Authors:  Hacer Akturk; Murat Sutcu; Ayper Somer; Derya Aydın; Rukiye Cihan; Aslı Ozdemir; Asuman Coban; Zeynep Ince; Agop Citak; Nuran Salman
Journal:  Braz J Infect Dis       Date:  2016-02-08       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.